5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The 1994 National Cancer Institute's strategy to fund multi-institutional, multidisciplinary consortia to design and conduct early phase clinical trials in patients with high grade gliomas
    Meeting Abstract

    Grossman, S. A.; Nabors, L. B.; Fisher, J. D.; Wen, P. Y.; Timmer, W. C.; Barker, F. G.; Peereboom, D. M.; Ellingson, B. M.; Supko, J. G.; Rudek, M. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • AMEERA-1: Phase 1/2 study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with palbociclib (palbo) in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER-2) metastatic breast cancer (mBC)
    Meeting Abstract

    Chandarlapaty, S.; Linden, H. M.; Neven, P.; Petrakova, K.; Bardia, A.; Kabos, P.; Braga, S. A. D. S.; Boni, V.; Gosselin, A.; Cartot-Cotton, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Trial in progress: Phase I/II study of radiation therapy followed by intrathecal trastuzumab/pertuzumab in the management of HER2(+) breast leptomeningeal disease
    Meeting Abstract

    Ahmed, K. A.; Kim, Y.; DeJesus, M.; Kumthekar, P.; Williams, N. O.; Palmer, J. D.; Giglio, P.; Boire, A. A.; Arrington, J.; Sahebjam, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer
    Meeting Abstract

    Sharifi, N.; Kruse, M. L.; McManus, J.; Chung, Y. M.; Wei, W.; Bazeley, P.; Nakamura, F.; Hardaway, A.; Kelley, E. D.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Impact of mutant IDH (mIDH) inhibition on DNA hydroxymethylation, tumor cell function, and tumor immune microenvironment (TIME) in resected mIDH1 lower-grade glioma (LGG)
    Meeting Abstract

    Lu, M.; Cloughesy, T. F.; Wen, P. Y.; Tassinari, A.; Choe, S.; Zhu, D.; Hassan, I.; Steelman, L.; Pandya, S. S.; Wu, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of brain metastases (BM) in non-small cell lung cancer (NSCLC): An AACR Project GENIE analysis
    Meeting Abstract

    Rahman, P.; LeNoue-Newton, M.; Chaugai, S.; Holt, M.; Jain, N. M.; Maxwell, C.; Micheel, C.; Yang, Y. J.; Ye, C.; Schultz, N.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
    Meeting Abstract

    Jee, J.; Lebow, E. S.; Murciano-Goroff, Y. R.; Jayakumaran, G.; Shen, R.; Brannon, A. R.; Benayed, R.; Namakydoust, A.; Offin, M.; Paik, P. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy
    Meeting Abstract

    Lavery, J. A.; Brown, S.; Riely, G. J.; Bedard, P. L.; Park, B. H.; Warner, J. L.; Kehl, K. L.; Lepisto, E. M.; Rizvi, H.; LeNoue-Newton, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies
    Meeting Abstract

    Murciano-Goroff, Y. R.; Schram, A. M.; Rosen, E.; Janjigian, Y. Y.; Berger, M. F.; Donoghue, M.; Bandlamudi, C.; Drilon, A. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors
    Meeting Abstract

    Sarfaty, M.; Desjardins, C. A.; Giardina, P.; Bardhan, K.; Pandian, S.; Halley, K.; Halvorsen, E. M.; Callahan, M. K.; Postow, M. A.; Lee, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save